CD274 and neoplasm: Spatial and temporal heterogeneity of PD-L1 expression have been described in NSCLC and may be a plausible explanation of PD-L1 status discordance observed between samples across studies [45,46,47], increasing the risk of false negatives in small samples with low tumor cellularity, such as those obtained from EBUS-TBNA.